东吴证券晨会纪要-20260313

Macro Strategy - The core viewpoint is that the February CPI data in the US met expectations, indicating an overall improvement in inflation after seasonal disturbances in January, alleviating concerns about core inflation stickiness [1][6][7] - The sustainability of rising oil prices is crucial for the US inflation outlook and the Federal Reserve's policy rate path in the coming months [1][6] - Short-term impacts of oil price surges are expected to be minimal on the March-April FOMC decisions, but if oil prices become uncontrollable, there may be a risk of a more hawkish stance from Powell [1][6][7] Fixed Income - The Longgao Convertible Bond (127113.SZ) is expected to list at a price between 121.24 and 135.07 CNY, with a subscription rate of 0.0035% [2][8] - The bond has a total issuance scale of 759 million CNY, with net proceeds allocated to various projects, including production base upgrades [2][8] Industry Insights Laopu Gold (06181.HK) - The company forecasts a net profit increase of 233% to 240% year-on-year for 2025, driven by brand influence, product optimization, and store expansion [3][10] - Revenue is expected to reach 27 to 28 billion CNY, with a significant increase in terminal sales due to multiple price hikes in 2025 [3][10] - The company maintains a "buy" rating with adjusted net profit forecasts for 2025-2027 increased to 48.9, 87.0, and 113.7 billion CNY, respectively [3][12] Chongqing Beer (600132) - The company reported a revenue of 14.72 billion CNY for 2025, a year-on-year increase of 0.53%, with a net profit of 1.23 billion CNY, up 10.43% [4][12] - The company maintains a high dividend policy with a payout ratio of 98.3% despite a challenging external environment [4][12] - Profitability remains stable, with a sales net profit margin of 16.83% for 2025 [4][12] Baicheng Pharmaceutical (301096) - The company is entering a harvest period for innovative drugs, with stable cash flow from generic drug CRO services [5][13] - The company holds over 100 product rights, with more than 30 approved, which are expected to contribute to a "second growth curve" [5][13] - The projected revenue for 2025-2027 is 707 million, 821 million, and 973 million CNY, with net profits of -79 million, 121 million, and 203 million CNY, respectively [5][14]